BackKindred Biosciences Overview

Kindred Biosciences Inventory

Track Kindred Biosciences's inventory ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00
↓ 100.00% YoYΔ $-389000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Kindred Biosciences Inventory History

Loading

Kindred Biosciences vs. peers: Inventory Comparison

Loading

Kindred Biosciences Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Kindred Biosciences (KIN) FAQ

Kindred Biosciences (KIN) currently reports a inventory of $0 as of June 2021. That compares with $390K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Kindred Biosciences's inventory history and peer comparisons.

Kindred Biosciences's inventory decreased from $390K to $0 — a 100.0% year-over-year decrease (period ending June 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kindred Biosciences reported $0 in inventory as of June 2021. That compares with $390K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kindred Biosciences, and consider following KIN for alerts when major investors trade the stock.

Kindred Biosciences is classified in the Healthcare sector. On inventory, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KIN with unrelated industries.